Cytometric Analysis News and Research

RSS
Novel vaccine platform against COVID-19 based on engineered human mesenchymal stem cells

Novel vaccine platform against COVID-19 based on engineered human mesenchymal stem cells

A novel approach to intraplaque mast cell characterization in atherosclerosis

A novel approach to intraplaque mast cell characterization in atherosclerosis

Beckman Coulter launches new ClearLLab 10C System for clinical flow cytometry lab

Beckman Coulter launches new ClearLLab 10C System for clinical flow cytometry lab

Image Cytometry Technology and Tissue Analysis

Image Cytometry Technology and Tissue Analysis

Adaptive Biotechnologies demonstrates use of high-throughput sequencing platform for MRD

Adaptive Biotechnologies demonstrates use of high-throughput sequencing platform for MRD

Phenotyping human diseases in mice: an interview with Professor Carola Vinuesa

Phenotyping human diseases in mice: an interview with Professor Carola Vinuesa

Key findings on plasma cell disorders to be presented at American Society of Hematology Annual Meeting

Key findings on plasma cell disorders to be presented at American Society of Hematology Annual Meeting

Study helps understand molecular mechanism underlying taurine's protection against hepatic fibrosis

Study helps understand molecular mechanism underlying taurine's protection against hepatic fibrosis

Research programme to develop immunological biomarkers for chronic inflammatory diseases

Research programme to develop immunological biomarkers for chronic inflammatory diseases

A potential therapeutic target for gastric cancer

A potential therapeutic target for gastric cancer

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.